首页> 外文期刊>Human Molecular Genetics >Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype
【24h】

Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype

机译:贩运rBAT突变的不同类别导致I型胱氨酸尿症表型

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Most mutations in the rBAT subunit of the heterodimeric cystine transporter rBAT-b0,+AT cause type I cystinuria. Trafficking of the transporter requires the intracellular assembly of the two subunits. Without its partner, rBAT, but not b0,+AT, is rapidly degraded. We analyzed the initial biogenesis of wild-type rBAT and type I cystinuria rBAT mutants. rBAT was degraded, at least in part, via the ERAD pathway. Assembly with b0,+AT within the endoplasmic reticulum (ER) blocked rBAT degradation and could be independent of the calnexin chaperone system. This system was, however, necessary for post-assembly maturation of the heterodimer. Without b0,+AT, wild-type and rBAT mutants were degraded with similar kinetics. In its presence, rBAT mutants showed strongly reduced (L89P) or no transport activity, failed to acquire complex N-glycosylation and to oligomerize, suggesting assembly and/or folding defects. Most of the transmembrane domain mutant L89P did not heterodimerize with b0,+AT and was degraded. However, the few [L89P]rBAT-b0,+AT heterodimers were stable, consistent with assembly, but not folding, defects. Mutants of the rBAT extracellular domain (T216M, R365W, M467K and M467T) efficiently assembled with b0,+AT but were subsequently degraded. Together with earlier results, the data suggest a two-step biogenesis model, with the early assembly of the subunits followed by folding of the rBAT extracellular domain. Defects on either of these steps lead to the type I cystinuria phenotype.
机译:异二聚体胱氨酸转运蛋白rBAT-b 0,+ AT的rBAT亚基中的大多数突变引起I型胱氨酸尿症。运输转运蛋白需要两个亚基的细胞内组装。如果没有其合作伙伴,rBAT会迅速降级,而b 0,+ AT不会。我们分析了野生型rBAT和I型胱氨酸尿症rBAT突变体的初始生物发生。 rBAT至少部分通过ERAD途径降解。内质网(ER)中的b 0,+ AT组装可阻止rBAT降解,并且可能独立于钙连蛋白伴侣蛋白系统。然而,该系统对于异二聚体的组装后成熟是必需的。没有b 0,+ AT,野生型和rBAT突变体以相似的动力学降解。在其存在下,rBAT突变体表现出强烈降低的(L89P)或没有运输活性,未能获得复杂的N-糖基化和寡聚化,表明存在组装和/或折叠缺陷。大部分跨膜结构域突变体L89P不与b 0,+ AT异源二聚体并被降解。然而,少数[L89P] rBAT-b 0,+ AT异二聚体是稳定的,与组装一致,但不折叠。 rBAT胞外域的突变体(T216M,R365W,M467K和M467T)与b 0,+ AT有效组装,但随后被降解。连同较早的结果,数据表明了两步生物发生模型,即亚基的早期组装,然后是rBAT胞外域的折叠。这些步骤中的任何一个步骤的缺陷都会导致I型胱氨酸尿症表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号